connect location-location-location-where-to-get-published 
FDA Law Blog
JULY 5, 2023
Palmer — Last week FDA published a long-awaited Draft Guidance for outsourcing facilities addressing the Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act (Draft Guidance). By Kalie E. Richardson & Karla L. See 21 U.S.C. 353b(a)(8).
pharmaphorum
NOVEMBER 23, 2022
They have suffered from an overwhelming diagnosis experience that has left them feeling misunderstood, isolated, and desperate for someone to help them connect symptoms and make sense of the sheer volume of information. Many will also face barriers to care, where access to specialists is limited and often geographically out of reach.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
VirTrial
JANUARY 10, 2020
Scottsdale, AZ (January 9, 2020) – VirTrial announced today that it has been selected as a winner in this year’s Fierce Innovation Awards – LifeSciences Edition, a peer reviewed awards program from the publisher of FierceBiotech and FiercePharma. Winners are profiled in the 2019 Innovation Report published by FierceHealthcare.
XTalks
JANUARY 20, 2021
Laboratory research is among the industries where work cannot be completed from home. The bench spaces where laboratory work is completed are small and close together, leaving little room for keeping distance between colleagues. Otherwise, a single failed experiment could put a research project significantly behind schedule.
pharmaphorum
MAY 20, 2022
This was the subject of a recent pharmaphorum webinar , developed in association with the National Institute of Health and Care Research (NIHR) where a panel of industry experts gathered to discuss how to unlock the promise of primary care sites in commercial research.
The Pharma Data
JANUARY 20, 2021
“Even patients who are closer, based on life burden and expectation, they might not be able to keep up with their appointments, so telehealth actually offers a way to remain connected with care, regardless of how busy people’s lives might be,” Severe said. . WEDNESDAY, Jan. That group was more likely to be older than 45.
pharmaphorum
DECEMBER 21, 2021
There are currently very few expert centres around the world that specialise in Rare Diseases, which means getting access to the people best placed to both diagnose and recommend a specific therapy is limited. Sub-heading: The challenges in serving patients. This leads back to the barriers in developing successful treatments.
Expert insights. Personalized for you.
52 
Let's personalize your content